← Open Payments lookup

PHILLIP RODGERS: Open Payments

NPI 1619700481 · DURANT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$514 in 23 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $246 · 2025 $514

Food & beverage: $514
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP10$278
Novo Nordisk Inc4$67
ABBVIE INC.2$36
GlaxoSmithKline, LLC.2$30
Bayer Healthcare Pharmaceuticals Inc.2$28
Otsuka America Pharmaceutical, Inc.1$27
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$24
CSL Behring1$23

Products named: FARXIGA, BREZTRI, Ozempic, UBRELVY, AIRSUPRA, TRELEGY ELLIPTA, Kerendia, REXULTI.

Industry payments across MS — which companies pay providers there.